CeriBell, Inc. (CBLL)
After hours:
| Previous Close | 26.43 |
| Open | 26.57 |
| Bid | 26.21 x 100 |
| Ask | 26.00 x 100 |
| Day's Range | 26.09 - 26.83 |
| 52 Week Range | 23.00 - 27.71 |
| Volume | |
| Avg. Volume | 649,500 |
| Market Cap | 935.82M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- TipRanks
Opening Day: Another trio of biotech IPOs make Friday debut
The Partners Group-backed KinderCare sold 24 million shares for $24 each this Tuesday. At the IPO price, the childhood education company had a market value of $2.74B, based on the outstanding shares. Sky Quarry, Click Holdings, and SKK Holdings also opened for trading this week. Meanwhile, a new trio of biotech companies’ shares came to market on Friday as Upstream Bio, Ceribell and Camp4 Therapeutics each made their public debut. In mid-September, Bicara Therapeutics (BCAX), MBX Biosciences (MB
- Bloomberg
CeriBell Shares Rise 47% to Lead Trio of Life Sciences IPOs
(Bloomberg) -- Three US life-sciences companies hitting the market delivered mostly robust early trading after investors strongly supported their initial public offerings.Most Read from BloombergDubai’s Allure to Expats Is Weighing on City’s InfrastructureThe Master Plan That Shaped Pakistan’s Capital Is No Longer WorkingThe Cablebus Transformed Commutes in Mexico City’s Populous OutskirtsAs Brussels Booms, an Old Boogeyman Returns: BrusselizationChicago Marathon to Honor Kenyan Who Died After H
